| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.28 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |